Heart failure and tachycardia-induced cardiomyopathy

被引：39

作者：

Ellis E.R. ^{[1
]}

Josephson M.E. ^{[2
]}

机构：

[1] Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA 02215

[2] Harvard Medical School, Beth Israel Deaconess Medical Center, Harvard-Thorndike Electrophysiology Institute, Boston, MA 02215

来源：

Current Heart Failure Reports | 2013年 / 10卷 / 4期

关键词：

Atrial fibrillation; Cardiomyopathy; Congestive heart failure; Premature ventricular contractions; Premature ventricular depolarizations; Supraventricular tachycardia; Tachycardia-induced cardiomyopathy; Tachycardia-mediated cardiomyopathy; Ventricular tachycardia;

D O I：

10.1007/s11897-013-0150-z

中图分类号：

学科分类号：

摘要：

Congestive heart failure is a major health care concern affecting almost six million Americans and an estimated 23 million people worldwide, and its prevalence is increasing with time. Long-standing tachycardia is a well-recognized cause of heart failure and left ventricular dysfunction and has led to the nomenclature, tachycardia-induced cardiomyopathy. Tachycardia-induced cardiomyopathy is generally a reversible cardiomyopathy with effective treatment of the causative arrhythmia, either with medications, surgery, or catheter ablation. Tachycardia-induced cardiomyopathy remains poorly understood and is likely under-diagnosed. A better understanding of tachycardia-induced cardiomyopathy and improved recognition of its presence in clinical practice is vital to the health of patients with this disorder. The goal of this review is to discuss the pathogenesis and clinical manifestations of tachycardia-induced cardiomyopathy, as well as approaches to its diagnosis and treatment. © 2013 Springer Science+Business Media New York.

引用

页码：296 / 306

页数：10

共 100 条

[1]

Lloyd-Jones D., Adams R.J., Brown T.M., Et al., Heart disease and stroke statistics-2010 update: A report from the American Heart Association, Circulation, 121, (2010)

[2]

McCullough P.A., Philbin E.F., Spertus J.A., Kaatz S., Sandberg K.R., Weaver W.D., Confirmation of a heart failure epidemic: Findings from the Resource Utilization among Congestive Heart Failure (REACH) study, J Am Coll Cardiol, 39, pp. 60-69, (2002)

[3]

Owan T.E., Redfield M.M., Epidemiology of diastolic heart failure, Progr Cardiovasc Dis, 47, pp. 320-332, (2005)

[4]

Gossage A.M., Braxton Hicks J., On auricular fibrillation, QJM, pp. 435-440, (1913)

[5]

Coleman III H.N., Taylor R.R., Pool P.E., Et al., Congestive heart failure following chronic tachycardia, Am Heart J, 81, pp. 790-798, (1971)

[6]

Armstrong P.W., Stopps T.P., Ford S.E., De Bold A.J., Rapid ventricular pacing in the dog: Pathophysiologic studies of heart failure, Circulation, 74, pp. 1075-1084, (1986)

[7]

Wilson J.R., Douglas P., Hickey W.F., Et al., Experimental congestive heart failure produced by rapid ventricular pacing in the dog: Cardiac effects, Circulation, 75, pp. 857-867, (1987)

[8]

Scott B.D., Sharma M.K., Levett J.M., Et al., Cardiac geometry and mass changes associated with pacing-induced cardiomyopathy in the dog, Am Heart J, 125, pp. 1047-1053, (1993)

[9]

Spinale F.G., Hendrick D.A., Crawford F.A., Smith A.C., Hamada Y., Carabello B.A., Chronic supraventricular tachycardia causes ventricular dysfunction and subendocardial injury in swine, Am J Physiol, 259, (1990)

[10]

Thackray S.D., Witte K.K., Nikitin N.P., Clark A.L., Kaye G.C., Cleland J.G., The prevalence of heart failure and asymptomatic left ventricular systolic dysfunction in a typical regional pacemaker population, Eur Heart J, 24, pp. 1143-1152, (2003)

← 1 2 3 4 5 6 7 8 9 10 →